Onito, Marcedita G.
HRN: 21-81-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
CEFUROXIME 1.5GM (VIAL)
08/16/2022
08/23/2022
IV
1.5g
Q8
Incomplete Abortion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes